HomeTLSI • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$5.65
Day range
$5.53 - $5.78
Year range
$3.50 - $10.24
Market cap
184.92M USD
Avg Volume
60.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 8.26M | 44.40% |
Operating expense | 16.37M | -15.69% |
Net income | -10.11M | 71.64% |
Net profit margin | -122.36 | 80.36% |
Earnings per share | -0.40 | 74.36% |
EBITDA | -9.13M | 35.17% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.52M | -27.61% |
Total assets | 23.97M | -2.55% |
Total liabilities | 49.86M | -3.48% |
Total equity | -25.89M | — |
Shares outstanding | 32.27M | — |
Price to book | -6.81 | — |
Return on assets | -90.60% | — |
Return on capital | -6,206.39% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -10.11M | 71.64% |
Cash from operations | -5.71M | 37.81% |
Cash from investing | -50.00K | 86.56% |
Cash from financing | 2.99M | 6,862.79% |
Net change in cash | -2.76M | 70.93% |
Free cash flow | -3.74M | 9.20% |
About
Founded
2009
Headquarters
Website
Employees
110